IQ Genomix at the 44th Panhellenic Congress of Gastroenterology

This year IQ Genomix participated in the 44th Panhellenic Congress of Gastroenterology, which was held at the Divani Caravel Hotel in Athens from November 28 to December 1, 2024.

The pioneering molecular test Colon AiQ, which detects colorectal cancer early with a simple blood test, was presented.

During the conference, many discussions were held with health professionals about the clinical value of the test and the benefits it offers to the examinees and the health system. The interest was intense, and the discussions were extremely constructive.

In the framework of the conference, a satellite lecture was held with Dr. Gilve and the title: “Colon AiQ – Prevention and early diagnosis of colorectal cancer using molecular techniques and artificial intelligence”.

Dr. Gilves presented the latest data and new methods of early detection by liquid biopsy. Colon AiQ stands out for its high sensitivity in detecting cancer even at early stages.

Stay tuned for more news on developments in the prevention and detection of colorectal cancer.